4.7 Article

Consistent multi-time-point brain atrophy estimation from the boundary shift integral

期刊

NEUROIMAGE
卷 59, 期 4, 页码 3995-4005

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2011.10.068

关键词

Boundary shift integral; Symmetric registration; Differential bias correction; Brain atrophy; Alzheimer's disease

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. National Institute on Aging
  3. National Institute of Biomedical Imaging and Bioengineering
  4. Abbott
  5. AstraZeneca AB
  6. Bayer Schering Pharma AG
  7. Bristol-Myers Squibb
  8. Eisai Global Clinical Development
  9. Elan Corporation
  10. Genentech
  11. GE Healthcare
  12. GlaxoSmithKline
  13. Innogenetics
  14. Johnson and Johnson
  15. Eli Lilly and Co.
  16. Medpace, Inc.
  17. Merck and Co., Inc.
  18. Novartis AG
  19. Pfizer Inc
  20. F. Hoffman-La Roche
  21. Schering-Plough
  22. Synarc, Inc.
  23. Alzheimer's Association
  24. Alzheimer's Drug Discovery Foundation
  25. NIH [P30 AG010129, K01 AG030514]
  26. Dana Foundation
  27. Department of Health's National Institute of Health Research Centres
  28. Medical Research Council
  29. Alzheimer's Research UK
  30. Medical Research Council [G0801306, G0601846] Funding Source: researchfish
  31. National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish
  32. MRC [G0801306, G0601846] Funding Source: UKRI

向作者/读者索取更多资源

Brain atrophy measurement is increasingly important in studies of neurodegenerative diseases such as Alzheimer's disease (AD), with particular relevance to trials of potential disease-modifying drugs. Automated registration-based methods such as the boundary shift integral (BSI) have been developed to provide more precise measures of change from a pair of serial MR scans. However, when a method treats one image of the pair (typically the baseline) as the reference to which the other is compared, this systematic asymmetry risks introducing bias into the measurement. Recent concern about potential biases in longitudinal studies has led to several suggestions to use symmetric image registration, though some of these methods are limited to two time-points per subject. Therapeutic trials and natural history studies increasingly involve several serial scans, it would therefore be useful to have a method that can consistently estimate brain atrophy over multiple time-points. Here, we use the log-Euclidean concept of a within-subject average to develop affine registration and differential bias correction methods suitable for any number of time-points, yielding a longitudinally consistent multi-time-point BSI technique. Baseline, 12-month and 24-month MR scans of healthy controls, subjects with mild cognitive impairment and AD patients from the Alzheimer's Disease Neuroimaging Initiative are used for testing the bias in processing scans with different amounts of atrophy. Four tests are used to assess bias in brain volume loss from BSI: (a) inverse consistency with respect to ordering of pairs of scans 12 months apart; (b) transitivity consistency over three time-points; (c) randomly ordered back-to-back scans, expected to show no consistent change over subjects; and (d) linear regression of the atrophy rates calculated from the baseline and 12-month scans and the baseline and 24-month scans, where any additive bias should be indicated by a non-zero intercept. Results indicate that the traditional BSI processing pipeline does not exhibit significant bias due to its use of windowed sinc interpolation, but with linear interpolation and asymmetric registration, bias can be pronounced. Either improved interpolation or symmetric registration alone can greatly reduce this bias, and our proposed method combining both aspects shows no significant bias in any of the four experiments. (C) 2011 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据